Product Name: LGR7 antibody [C3-2], C-term
Applications: WB
Predicted Target Size: 87 kDa (note) (7)
Positive Controls: 293T , H1299
Form Supplied: Liquid
Concentration: 0.4 mg/ml (Please refer to the vial label for the specific concentration)
Purification: Purified by antigen-affinity chromatography.
Full Name: relaxin/insulin-like family peptide receptor 1
Background: Receptor for relaxins. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. Binding of the ligand may also activate a tyrosine kinase pathway that inhibits the activity of a phosphodiesterase that degrades cAMP.
Synonyms: LGR7 antibody, LGR7.1 antibody, LGR7.10 antibody, LGR7.2 antibody, MGC138347 antibody, MGC142177 antibody, RXFPR1 antibody, RXFP1 antibody, relaxin receptor 1 antibody, leucine-rich repeat-containing G protein-coupled receptor 7 antibody, relaxin/insulin-like family peptide receptor 1 antibody
Cellular Localization: Cell membrane; Multi-pass membrane protein
CAS NO: 57-63-6
Product: ML277
Host: Rabbit
Clonality: Polyclonal
Isotype: IgG
Immunogen: Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human LGR7. The exact sequence is proprietary.
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Storage Instruction: Keep as concentrated solution. Aliquot and store at -20ÂșC or below. Avoid multiple freeze-thaw cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19414648?dopt=Abstract